Cargando…
Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice
Heme oxygenase-1 (Hmox1) is a stress-inducible protein crucial in heme catabolism. The end products of its enzymatic activity possess anti-oxidative, anti-apoptotic and anti-inflammatory properties. Cardioprotective effects of Hmox1 were demonstrated in experimental models of myocardial infarction (...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440541/ https://www.ncbi.nlm.nih.gov/pubmed/28534119 http://dx.doi.org/10.1007/s00395-017-0629-y |
_version_ | 1783238080742817792 |
---|---|
author | Tomczyk, Mateusz Kraszewska, Izabela Szade, Krzysztof Bukowska-Strakova, Karolina Meloni, Marco Jozkowicz, Alicja Dulak, Jozef Jazwa, Agnieszka |
author_facet | Tomczyk, Mateusz Kraszewska, Izabela Szade, Krzysztof Bukowska-Strakova, Karolina Meloni, Marco Jozkowicz, Alicja Dulak, Jozef Jazwa, Agnieszka |
author_sort | Tomczyk, Mateusz |
collection | PubMed |
description | Heme oxygenase-1 (Hmox1) is a stress-inducible protein crucial in heme catabolism. The end products of its enzymatic activity possess anti-oxidative, anti-apoptotic and anti-inflammatory properties. Cardioprotective effects of Hmox1 were demonstrated in experimental models of myocardial infarction (MI). Nevertheless, its importance in timely resolution of post-ischemic inflammation remains incompletely understood. The aim of this study was to determine the role of Hmox1 in the monocyte/macrophage-mediated cardiac remodeling in a mouse model of MI. Hmox1 knockout (Hmox1(−/−)) and wild-type (WT, Hmox1(+/+)) mice were subjected to a permanent ligation of the left anterior descending coronary artery. Significantly lower incidence of left ventricle (LV) free wall rupture was noted between 3rd and 5th day after MI in Hmox1(−/−) mice resulting in their better overall survival. Then, starting from 7th until 21st day post-MI a more potent deterioration of LV function was observed in Hmox1(−/−) than in the surviving Hmox1(+/+) mice. This was accompanied by higher numbers of Ly6C(hi) monocytes in peripheral blood, as well as higher expression of monocyte chemoattractant protein-1 and adhesion molecules in the hearts of MI-operated Hmox1(−/−) mice. Consequently, a greater post-MI monocyte-derived myocardial macrophage infiltration was noted in Hmox1-deficient individuals. Splenectomy decreased the numbers of circulating inflammatory Ly6C(hi) monocytes in blood, reduced the numbers of proinflammatory cardiac macrophages and significantly improved the post-MI LV function in Hmox1(−/−) mice. In conclusion, Hmox1 deficiency has divergent consequences in MI. On the one hand, it improves early post-MI survival by decreasing the occurrence of cardiac rupture. Afterwards, however, the hearts of Hmox1-deficient mice undergo adverse late LV remodeling due to overactive and prolonged post-ischemic inflammatory response. We identified spleen as an important source of these cardiovascular complications in Hmox1(−/−) mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-017-0629-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5440541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-54405412017-06-08 Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice Tomczyk, Mateusz Kraszewska, Izabela Szade, Krzysztof Bukowska-Strakova, Karolina Meloni, Marco Jozkowicz, Alicja Dulak, Jozef Jazwa, Agnieszka Basic Res Cardiol Original Contribution Heme oxygenase-1 (Hmox1) is a stress-inducible protein crucial in heme catabolism. The end products of its enzymatic activity possess anti-oxidative, anti-apoptotic and anti-inflammatory properties. Cardioprotective effects of Hmox1 were demonstrated in experimental models of myocardial infarction (MI). Nevertheless, its importance in timely resolution of post-ischemic inflammation remains incompletely understood. The aim of this study was to determine the role of Hmox1 in the monocyte/macrophage-mediated cardiac remodeling in a mouse model of MI. Hmox1 knockout (Hmox1(−/−)) and wild-type (WT, Hmox1(+/+)) mice were subjected to a permanent ligation of the left anterior descending coronary artery. Significantly lower incidence of left ventricle (LV) free wall rupture was noted between 3rd and 5th day after MI in Hmox1(−/−) mice resulting in their better overall survival. Then, starting from 7th until 21st day post-MI a more potent deterioration of LV function was observed in Hmox1(−/−) than in the surviving Hmox1(+/+) mice. This was accompanied by higher numbers of Ly6C(hi) monocytes in peripheral blood, as well as higher expression of monocyte chemoattractant protein-1 and adhesion molecules in the hearts of MI-operated Hmox1(−/−) mice. Consequently, a greater post-MI monocyte-derived myocardial macrophage infiltration was noted in Hmox1-deficient individuals. Splenectomy decreased the numbers of circulating inflammatory Ly6C(hi) monocytes in blood, reduced the numbers of proinflammatory cardiac macrophages and significantly improved the post-MI LV function in Hmox1(−/−) mice. In conclusion, Hmox1 deficiency has divergent consequences in MI. On the one hand, it improves early post-MI survival by decreasing the occurrence of cardiac rupture. Afterwards, however, the hearts of Hmox1-deficient mice undergo adverse late LV remodeling due to overactive and prolonged post-ischemic inflammatory response. We identified spleen as an important source of these cardiovascular complications in Hmox1(−/−) mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-017-0629-y) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-05-22 2017 /pmc/articles/PMC5440541/ /pubmed/28534119 http://dx.doi.org/10.1007/s00395-017-0629-y Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Contribution Tomczyk, Mateusz Kraszewska, Izabela Szade, Krzysztof Bukowska-Strakova, Karolina Meloni, Marco Jozkowicz, Alicja Dulak, Jozef Jazwa, Agnieszka Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice |
title | Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice |
title_full | Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice |
title_fullStr | Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice |
title_full_unstemmed | Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice |
title_short | Splenic Ly6C(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice |
title_sort | splenic ly6c(hi) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice |
topic | Original Contribution |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440541/ https://www.ncbi.nlm.nih.gov/pubmed/28534119 http://dx.doi.org/10.1007/s00395-017-0629-y |
work_keys_str_mv | AT tomczykmateusz splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice AT kraszewskaizabela splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice AT szadekrzysztof splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice AT bukowskastrakovakarolina splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice AT melonimarco splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice AT jozkowiczalicja splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice AT dulakjozef splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice AT jazwaagnieszka splenicly6chimonocytescontributetoadverselatepostischemicleftventricularremodelinginhemeoxygenase1deficientmice |